Header Logo

Connection

STEPHEN YENZEN LAI to Thyroid Neoplasms

Back to Details
This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Thyroid Neoplasms.
STEPHEN YENZEN LAI
Connection Strength
4.660
Thyroid Neoplasms
  1. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4652-e4665.
    View in: PubMed
    Score: 0.363
  2. A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab. 2021 09 27; 106(10):2962-2978.
    View in: PubMed
    Score: 0.361
  3. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head Neck. 2017 07; 39(7):1291-1295.
    View in: PubMed
    Score: 0.266
  4. Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base. Head Neck. 2016 06; 38(6):906-12.
    View in: PubMed
    Score: 0.244
  5. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model. Mol Cancer Ther. 2015 Dec; 14(12):2901-8.
    View in: PubMed
    Score: 0.238
  6. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia. Thyroid. 2015 Jul; 25(7):834-8.
    View in: PubMed
    Score: 0.232
  7. In reply. Oncologist. 2014 Aug; 19(8):e4.
    View in: PubMed
    Score: 0.220
  8. Evaluation of hyperpolarized [1-??C]-pyruvate by magnetic resonance to detect ionizing radiation effects in real time. PLoS One. 2014; 9(1):e87031.
    View in: PubMed
    Score: 0.212
  9. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther. 2012 Jun; 11(6):1373-80.
    View in: PubMed
    Score: 0.189
  10. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
    View in: PubMed
    Score: 0.172
  11. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol. 2024 Sep 01; 10(9):1264-1271.
    View in: PubMed
    Score: 0.111
  12. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep. 2024 Mar 26; 43(3):113826.
    View in: PubMed
    Score: 0.107
  13. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest. 2023 06 01; 133(11).
    View in: PubMed
    Score: 0.101
  14. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid. 2023 04; 33(4):484-491.
    View in: PubMed
    Score: 0.100
  15. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer. Thyroid. 2023 03; 33(3):321-329.
    View in: PubMed
    Score: 0.100
  16. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid. 2023 01; 33(1):129-132.
    View in: PubMed
    Score: 0.099
  17. Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers. Endocr Relat Cancer. 2022 11 01; 29(11):R173-R190.
    View in: PubMed
    Score: 0.097
  18. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precis Oncol. 2022 08; 6:e2100504.
    View in: PubMed
    Score: 0.096
  19. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol. 2020 09 01; 6(9):1397-1404.
    View in: PubMed
    Score: 0.084
  20. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2019 08; 29(8):1036-1043.
    View in: PubMed
    Score: 0.078
  21. Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies. Clin Cancer Res. 2019 05 15; 25(10):3141-3151.
    View in: PubMed
    Score: 0.075
  22. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid. 2018 08; 28(8):982-990.
    View in: PubMed
    Score: 0.073
  23. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2018 02 01; 144(2):108-114.
    View in: PubMed
    Score: 0.070
  24. Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2017 12 01; 143(12):1244-1251.
    View in: PubMed
    Score: 0.069
  25. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer. Head Neck. 2018 Jan; 40(1):79-85.
    View in: PubMed
    Score: 0.069
  26. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid. 2017 05; 27(5):672-681.
    View in: PubMed
    Score: 0.066
  27. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. Cancer. 2017 05 01; 123(9):1653-1661.
    View in: PubMed
    Score: 0.065
  28. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma. Thyroid. 2017 01; 27(1):81-87.
    View in: PubMed
    Score: 0.065
  29. Thyroid Gland Malignancies. Hematol Oncol Clin North Am. 2015 Dec; 29(6):1123-43.
    View in: PubMed
    Score: 0.060
  30. Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC. J Clin Endocrinol Metab. 2015 Dec; 100(12):E1550-9.
    View in: PubMed
    Score: 0.060
  31. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol. 2015 Dec; 42(6):915-22.
    View in: PubMed
    Score: 0.060
  32. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials. 2015 Jul; 57:41-9.
    View in: PubMed
    Score: 0.058
  33. Development and characterization of six new human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab. 2015 Feb; 100(2):E243-52.
    View in: PubMed
    Score: 0.056
  34. Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist. 2014 Mar; 19(3):251-8.
    View in: PubMed
    Score: 0.053
  35. Detection of thyroid cancer stem cells in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2014 Feb; 99(2):536-44.
    View in: PubMed
    Score: 0.053
  36. Radial spectroscopic MRI of hyperpolarized [1-(13) C] pyruvate at 7 tesla. Magn Reson Med. 2014 Oct; 72(4):986-95.
    View in: PubMed
    Score: 0.052
  37. Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck. 2014 Mar; 36(3):375-84.
    View in: PubMed
    Score: 0.051
  38. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Mol Cancer Ther. 2010 Jul; 9(7):1968-76.
    View in: PubMed
    Score: 0.041
  39. Minimally invasive video-assisted thyroidectomy: expanded indications and oncologic completeness. Head Neck. 2008 Nov; 30(11):1403-7.
    View in: PubMed
    Score: 0.037
  40. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy. Front Immunol. 2024; 15:1369780.
    View in: PubMed
    Score: 0.027
  41. A novel perfused Bloch-McConnell simulator for analyzing the accuracy of dynamic hyperpolarized MRS. Med Phys. 2016 Feb; 43(2):854-64.
    View in: PubMed
    Score: 0.015
  42. High-throughput hyperpolarized (13)C metabolic investigations using a multi-channel acquisition system. J Magn Reson. 2015 Nov; 260:20-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.